Symyx Technologies, Inc. (Nasdaq:SMMX), Santa Clara, Calif., has reported financial results for year-to-date and the second quarter ended June 30, 2004.
Revenue for the quarter was $18.9 million compared with $15.0 million for the same quarter in 2003, consisting of $10.4 million in service revenue from research collaborations, $5.5 million from Discovery Tools(R) product sales and $3.0 million in license fees and royalties. Service revenue includes $375,000 of revenue from Ilypsa Inc., formerly known as Symyx Therapeutics, Inc., a related party. The 26% increase in quarterly revenue resulted largely from the expansion of revenue under the Symyx Exxon Mobil Corp. …
No comments:
Post a Comment